What Are the Clinical Implications of New Onset or Worsening Anxiety During the First Two Weeks of SSRI Treatment for Depression?

OBJECTIVE: To evaluate the prevalence of new onset or worsening of anxiety symptoms, as well as their clinical implications, during the first two weeks of Selective Serotonin Reuptake Inhibitor (SSRI) pharmacotherapy for depression. METHOD: Adult outpatients with non-psychotic major depressive disor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gollan, Jackie K, Fava, Maurizio, Kurian, Benji, Wisniewski, Stephen R., Rush, A. John, Daly, Ella, Miyahara, Sachiko, Trivedi, Madhukar H.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3860362/
https://ncbi.nlm.nih.gov/pubmed/22147631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/da.20917
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares